The Quality Use of Medicines Maximised for Aboriginal and Torres Strait Islander People (QUMAX) Program is aimed at improving the Quality Use of Medicines and access to culturally appropriate services for Patients who identify as Aboriginal and/or Torres Strait Islander.

The QUMAX Program supports services provided by Aboriginal Community Controlled Health Organisations (ACCHOs) and Community Pharmacists who participate in the Program. Information about ACCHOs can be found on the National Aboriginal Community Controlled Health Organisation (NACCHO) website.

The Program provides support in seven categories:

  • Dose Administration Aid (DAA) arrangements
  • Quality Use of Medicines (QUM) pharmacy support
  • Home Medicines Review (HMR) models of support
  • QUM devices
  • QUM education
  • Cultural awareness
  • Transport.

Community Pharmacy Participation

Community Pharmacies will be eligible to participate in the QUMAX Program if they are an approved Section 90 Pharmacy and have agreed to the QUMAX Program Rules.

Community Pharmacies that are interested in participating in the QUMAX Program will enter into an agreement with the registered ACCHO in their area to meet the health needs of the local community. This can be either a formal contract or a flexible funding arrangement.

Aboriginal Community Controlled Health Organisation Participation

ACCHOs will be eligible to participate in the QUMAX Program if they:

  • Employ a General Practitioner
  • Are located in a non-remote area (category 1-5 of the Rural, Remote and Metropolitan Areas Classification (RRMA), 1991 Census Edition)
  • Are not currently eligible for the Section 100 Pharmacy Support Allowance Program
  • Agree to the QUMAX Program Rules
  • Be funded by the Indigenous Health Division for the provision of primary healthcare.

ACCHOs that participate in the QUMAX Program will enter into a contract with the Pharmacy Programs Administrator. Contracts will be renewed annually.

Community Pharmacies

Community Pharmacies are required to submit three reports each financial year, with evidence of the number of DAAs provided to each ACCHO they have a DAA Agreement with. Reports can be completed on the Pharmacy Programs Administrator Portal. Please note, Community Pharmacies are not required to submit DAA Reports to the Pharmacy Programs Administrator if they have a flexible funding agreement with an ACCHO; however, they may still be required to report on DAA services to the ACCHO they have the agreement with.

Community Pharmacy reporting periods:

Report Reporting Period Due Date
First Report 1 July – 31 October 15 November
Second Report 1 November – 28 February 15 March
Third Report 1 March – 30 June 15 July

ACCHOs

ACCHOs are required to submit two Progress Reports to the National Aboriginal Community Controlled Health Organisation (NACCHO) and the Pharmacy Programs Administrator within 30 days of the end of each six-month reporting period.

Reporting Period Due Date
1 July – 31 December 30 January
1 January – 30 June 30 July

Payments

ACCHOs receive payments in two instalments. If a DAA Agreement (Form A) is in place, Community Pharmacies receive payments in three instalments. If there is a flexible funding arrangement, the ACCHO will receive funding and disburse to the Community Pharmacies per their local-level arrangements. Upon execution of the contract between the ACCHO and the Pharmacy Programs Administrator, both the ACCHO and the Community Pharmacy will receive the first instalment of QUMAX Program funds. Community Pharmacies receive the second instalment after the first DAA Report is received and accepted. The third instalment is received after the second DAA Report is received and accepted. The third DAA Report is required for completion of the contract, but there are no payments associated with the submission of this report. ACCHOs will receive the second and final instalment after the first Progress Report is received and accepted. The second Progress Report is required for completion of the contract, but there are no payments associated with the submission of this report. ACCHO registration, work plans and progress reports are completed using the standard template developed by NACCHO and submitted to qumax@naccho.org.au. For further information, please contact:

QUMAX FAQ

  1. Approved ACCHOs will not need to register on the Pharmacy Programs Administrator Portal.

  2. Payments will be administered through the Portal, and each provider will be notified via email when a payment is made.

  3. For approved ACCHOs, all reporting is sent to the NACCHO QUMAX Co-ordinator. Community Pharmacy DAA Reports are to be uploaded to the Pharmacy Programs Administrator Portal.

  4. The work plan should be split into seven categories:

    • Dose Administration Aids (DAA Arrangements)
    • QUM Pharmacy Support
    • Home Medicines Review (HMR) modes of support
    • QUM Devices
    • QUM Education
    • Cultural Awareness
    • Transport

    Detailed information about these seven categories can be found in the Program Rules.

  5. No. Applications to register for the Program are made through NACCHO. Information about registering for the Program can be found at the NACCHO website.

  6. Please see the Eligibility Criteria for ACCHOs and Community Pharmacies with regard to S100 Pharmacy Support Allowance and QUMAX participation.

  7. Funding is calculated based on various factors outlined in the Program Rules.

  8. ACCHO reports are due every 6 months. Community Pharmacy DAA reports are due every four months in November, March and July. Further information about the reporting process can be found in the Program Rules.